14
O.A. El-Gammal et al. / Journal of Molecular Structure 1020 (2012) 6–15
Table 6
i. One C@O, two (C@N)azomethine, one NH and two (C@N)pyridine
groups free in the carbohydrazone, H2APC moitey. So, it
showed the potent antioxidant activity [59].
Antioxidant erythrocyte hemolysis assay for the prepared ligand and its metal
complexes.
Compound
-ascorbic acida
ABTS inhibition (%)
96.57
Erythrocyte hemolysis (%)
4.08
ii. In Cd(II) complex, there are still four donor sites free i.e. two
(C@N)pyridine and two NH groups that can donate an electron
or hydrogen radical thus be converted into a stable diamag-
netic molecule [60].
iii. In case of the binuclear Zn(II) complex, there is only one NH
group free. However its moderate activity can be referred to
the presence of three acetate groups which enhances the
scavenging activity.
L
H2APC
53.90
18.09
12.76
9.71
4.48
5.17
4.48
Zn-complex
Cd-complex
Hg-complex
31.15
a
Standard drug.
iv. In Hg(II) complex showed no activity owing to its well
known high toxicity although it most of the donor sites free
otherwise C@O group.
i) The high values of the energy of activation, Ea of the com-
plexes reveals the high stability of such chelates due to their
covalent bond character [55] and the increase of Ea on going
from Zn(II) complex to Cd(II) complex reflects the greater
thermal stability of first complex than the second one as Ea
depends on the strength of (O ? M N) and increases with
increasing the cation radius.
4. Conclusion
1,5-Bis(1-(pyridin-2-yl)ethylidene)carbonohydrazide (H2APC)
and its mono- and binuclear complexes with Zn acetate, Cd(II)
and Hg(II) chlorides were prepared. The complexes have been
characterized and assigned the formulae [Zn2(HAPC)(OA-
c)3(H2O)3]ꢂ3H2O, [Cd(H2APC)Cl2] and [Hg2(H2APC)2Cl4]. A trigonal
bipyramidal was proposed for Cd(II)complex, an octahedral for
Zn(II) complex and a tetrahedral geometries, respectively. The li-
gand and its complexes were screened for antioxidant activity
(using DPPH and ABTS+), erythrocyte hemolysis and in vitro Ehrlich
ascites assay. The relation between the structure of the studied
compounds and their activity was discussed. All the data obtained
revealed the high activity of Cd(II) and Zn(II) complexes and very
weak activity for Hg(II) complex.
ii) The positive sign of
DG for the investigated complexes
reveals that the free energy of the final residue is higher than
that of the initial compound, and all the decomposition steps
are non-spontaneous processes. Also, the values of the acti-
vation,
position stages of a given complex. This is due to increasing
the values of T S significantly from one step to another
which overrides the values of H [56–58].
iii) The negative values of S for the degradation process indi-
DG increases significantly for the subsequent decom-
D
D
D
cates more ordered activated complex than the reactants
or the reaction is slow [54].
3.7. Biological application
Appendix A. Supplementary material
3.7.1. Antioxidant activity
Supplementary data associated with this article can be found, in
3.7.1.1. DPPH free radical scavenging activity. We found that most of
compounds showed considerable free radical-scavenging activities
(Fig. 7a). H2APC was the strongest radical scavenger among the
studied compounds with IC50 9.64 mg/ml comparable with ascor-
bic acid (standard antioxidant). Zn(II) and Cd(II) complexes showed
moderate scavenging activity with IC50 32.88 and 42.97 mg/ml,
respectively. On the other hand, Hg(II) complex exhibited no activ-
ity. The variation of % DPPH radical scavenging activity with con-
centration of test compounds is represented in Fig. 7b.
References
[1] G. Wilkinson, R.D. Gillard, J.A. McCleverty, Comprehensive Coordination
Chemistry, vol. 2, Elsevier, Oxford, 1987.
[2] Yan Wang, Zheng Yin Yang, Bao-dui Wang, Trans. Met. Chem. 30 (2005) 879–
883.
[3] D.W. Maragerum, G.D. Owens, H. Sigel, Metal Ions in Biological Systems, vol.
12, Marcel Dekker Inc., New York, 1981. 75.
[4] J. Chakraborty, B. Samanta, G. Pilet, S. Mitra, Struct. Chem. 17 (6) (2006) 585–
593.
[5] A. Shrivastav, N.K. Singh, P. Tripathi, et al., Biochimie 88 (9) (2006) 1209–1216.
[6] Z.H. Chohan, H. Pervez, K.M. Khan, C.T. Supuran, J. Enzyme Inhib. Med. Chem.
20 (1) (2005) 81–89.
[7] H.-J. Cristau, P.P. Cellier, J.-F. Spindler, M. Taillefer, Eur. J. Org. Chem. 4 (2004)
695–709.
[8] G.F. de Sousa, M.B.P. Mangas, R.H.P. Francisco, M.T. do P. Gambardella, A.M.G.D.
Rodrigues, A. Barras, J. Braz. Chem. Soc. 10 (3) (1999) 222–230.
[9] A. Bacchi, G. Pelizzi, D. Jeremic´, D. Sladic´, M. Gruden-Pavlovic´, K. Andjelkovic´,
Trans. Met. Chem. 28 (2003) 935–938.
[10] C. Pelizzi, G. Pelizzi, G. Predieri, J. Organometal. Chem. 263 (1984) 9–20.
[11] D. Wester, G.J. Palenik, Inorg. Chem. 15 (1976) 755–761.
[12] A. Bino, R. Frim, M.V. Genderen, Inorg. Chim. Acta 127 (1987) 95–101.
[13] M. Mohan, P. Sharma, N.K. Jha, Inorg. Chim. Acta 107 (1985) 91–95.
[14] D. Wester, G.J. Palenik, J. Am. Chem. Soc. 95 (1973) 6505–6506.
[15] C. Aliage, E.A. Lissi, Int. J. Chem. Kinet. 30 (1998) 565–570.
[16] M. Cuendet, K. Hostettmann, O. Potterat, W. Dyatmiko, Helv. Chim. Acta 80
(1997) 1144–1152.
[17] M. Burits, F. Bucar, Phytother. Res. 14 (2000) 323–328.
[18] E.A. Lissi, B. Modak, R. Torres, J. Escobar, A. Urzua, Free Radical Res. 30 (1999)
471–477.
[19] A.B.A. El-Gazzar, M.M. Youssef, A.M.S. Youssef, A.A. Abu-Hashem, F.A. Badria,
Eur. J. Med. Chem. 44 (2009) 609–624.
3.7.1.2. Antioxidant activity using ABTS inhibition and erythrocyte
hemolysis. All compounds were tested for antioxidant activity
using ABTS assay and rate erythrocyte hemolysis (Table 6). An
inspection of the data in the table indicates that H2APC exhibits
the potent anti-oxidative activity. On the other hand, Zn(II) and
Cd(II) complexes showed moderate activity while Hg(II) complex
exhibited very weak or no antioxidant activity. With respect to
erythrocyte hemolysis, the compounds can be arranged in the se-
quence: H2APC = Cd(II) complex > Zn(II) complex > Hg(II) complex.
3.7.2. Antitumor activity using in vitro Ehrlich ascites assay
The compounds were screened for their antitumor activity
(Fig. 8a). H2APC showed the highest cytotoxic activity (61.41%)
comparable to 5-furacil (standard drug) followed by Zn(II) and
Cd(II) complexes. Hg(II) complex exhibited no cytotoxic activity.
The variation of % inhibition of Ehrlich antitumor activity with con-
centration of test compounds is shown in Fig. 8b.
[20] R. Aeschbach, J. Loliger, B.C. Scott, A. Murcia, J. Butler, B. Halliwell, O.I. Aruoma,
Food Chem. Toxicol. 32 (1994) 31–36.
[21] Y. Morimoto, K. Tanaka, Y. Iwakiri, S. Tokuhiro, S. Fukushima, Y. Takeuchi, Biol.
Pharm. Bull. 18 (1995) 1417–1422.
3.7.3. Structure activity relationship (SAR)
The antioxidant, erythrocyte hemolysis and antitumor activities
of the investigated compounds is due to the presence of:
[22] A.A. Fadda, F.A. Badria, K.M. El-Attar, Med. Chem. Res. 19 (2010) 413–430.